v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 94,431 $ 60,698
Short-term investments 188,491 248,933
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 10,302 11,664
Total current assets 293,418 321,489
Property and equipment, net 55,697 68,576
Operating lease assets 14,204 0
Restricted cash - long-term 1,200 1,200
Other assets 266 574
Total assets 364,785 391,839
Current liabilities:    
Accounts payable 5,155 3,719
Accrued compensation 12,897 10,636
Accrued research and development expenses 6,172 19,210
Other current liabilities 6,482 6,414
Total current liabilities 30,706 39,979
Operating lease liabilities - long-term 14,532 0
Other long-term liabilities 1,105 13,003
Total liabilities 46,343 52,982
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of September 30, 2019 and December 31, 2018, respectively; 54,125 and 45,951 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 5 5
Additional paid-in capital 1,057,669 866,541
Accumulated other comprehensive income (loss) 233 (340)
Accumulated deficit (739,465) (527,349)
Total stockholders’ equity 318,442 338,857
Total liabilities and stockholders’ equity $ 364,785 $ 391,839

Source